Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析

◆英語タイトル:Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1608
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sartorius Stedim Biotech SA (DIM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentors, moisture analyzers, filters, bioreactors, shakers, virus purification kits and centrifuges, among others. SSB services include bioprocess development and engineering, protein expression systems, media and process; instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa and Asia-Pacific. SSB is headquartered in Aubagne, France.

Sartorius Stedim Biotech SA Key Recent Developments

Apr 21,2020 Sartorius Stedim Biotech with a strong start in 2020
Mar 17,2020 Sartorius Stedim Biotech postpones Annual Shareholders’ Meeting
Feb 24,2020 Sartorius introduces BioPAT Spectro to enable Raman Spectroscopy capability and QbD with its ambr and BIOSTAT STR platforms
Feb 18,2020 Sartorius Stedim Biotech confirms preliminary figures; strong outlook for 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sartorius Stedim Biotech SA – Key Facts
Sartorius Stedim Biotech SA – Key Employees
Sartorius Stedim Biotech SA – Key Employee Biographies
Sartorius Stedim Biotech SA – Major Products and Services
Sartorius Stedim Biotech SA – History
Sartorius Stedim Biotech SA – Company Statement
Sartorius Stedim Biotech SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sartorius Stedim Biotech SA – Business Description
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
Sartorius Stedim Biotech SA – Corporate Strategy
Sartorius Stedim Biotech SA – SWOT Analysis
SWOT Analysis – Overview
Sartorius Stedim Biotech SA – Strengths
Sartorius Stedim Biotech SA – Weaknesses
Sartorius Stedim Biotech SA – Opportunities
Sartorius Stedim Biotech SA – Threats
Sartorius Stedim Biotech SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Sartorius Stedim Biotech SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2020: Sartorius Stedim Biotech with a strong start in 2020
Mar 17, 2020: Sartorius Stedim Biotech postpones Annual Shareholders’ Meeting
Feb 24, 2020: Sartorius introduces BioPAT Spectro to enable Raman Spectroscopy capability and QbD with its ambr and BIOSTAT STR platforms
Feb 18, 2020: Sartorius Stedim Biotech confirms preliminary figures; strong outlook for 2020
Jan 28, 2020: Sartorius Stedim Biotech grows by double digits in 2019; strong outlook for 2020
Nov 13, 2019: Sartorius improves delivery performance & customer experience with Celonis process mining
Oct 21, 2019: Sartorius Stedim Biotech launches new Sartocheck 5 Plus Filter Tester
Jun 22, 2019: Sartorius debuts the Intellicyt iQue3 at CYTO 2019
Jun 19, 2019: Sartorius starts up operations at expanded site in Puerto Rico
Jun 18, 2019: Siemens supports Chinese pharmaceutical companies in digital transformation
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sartorius Stedim Biotech SA, Key Facts
Sartorius Stedim Biotech SA, Key Employees
Sartorius Stedim Biotech SA, Key Employee Biographies
Sartorius Stedim Biotech SA, Major Products and Services
Sartorius Stedim Biotech SA, History
Sartorius Stedim Biotech SA, Subsidiaries
Sartorius Stedim Biotech SA, Key Competitors
Sartorius Stedim Biotech SA, Ratios based on current share price
Sartorius Stedim Biotech SA, Annual Ratios
Sartorius Stedim Biotech SA, Annual Ratios (Cont...1)
Sartorius Stedim Biotech SA, Annual Ratios (Cont...2)
Sartorius Stedim Biotech SA, Interim Ratios
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Sartorius Stedim Biotech SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sartorius Stedim Biotech SA, Performance Chart (2015 - 2019)
Sartorius Stedim Biotech SA, Ratio Charts
Sartorius Stedim Biotech SA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Sartorius Stedim Biotech SA, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thai Airways International Public Co Ltd
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • Canada Life Ltd:企業の戦略・SWOT・財務情報
    Canada Life Ltd - Strategy, SWOT and Corporate Finance Report Summary Canada Life Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Akzo Nobel NV (AKZA):企業の財務・戦略的SWOT分析
    Akzo Nobel NV (AKZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Baloise Holding Ltd:企業の戦略・SWOT・財務分析
    Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Baloise Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Paramo AS:企業の戦略的SWOT分析
    Paramo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • ProterixBio Inc:医療機器:M&Aディール及び事業提携情報
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc, is a medical device company that manufactures and markets ViBE platform products. The company offers ViBE platform, acoustic assays, ViBE software and custom assays, among others. Its ViBE platform enables non-optical detection and sensit …
  • Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nobelpharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company which develops medicines for rare diseases and unmet medical needs. The Company’s pipeline products include NPC-07, NPC-09, NPC-12, NPC-14, NPC-15, NPC-16, NPC-17 and NPC-18. It offers its products in the therapeutic areas of oncol …
  • UniQuest Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a dispos …
  • Bajaj Corp Limited:企業の戦略・SWOT・財務分析
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Siam Cement Public Co Ltd:戦略・SWOT・企業財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Medica Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medica Corp (Medica) is a medical device company that manufactures and markets in-vitro diagnostic blood testing analyzers. The company’s products comprise clinical chemistry analyzers, electrolyte analyzers, blood gas analyzers, and hematology analyzers, and OEM ISE modules. Medica’s produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆